In this study, we extended previous findings and revealed that GA markedly protected against the Ang II-induced degradation of eNOS by inhibiting the immunoproteasome subunits β2i and β5i, leading to an improvement of endothelial dysfunction (Figures 2–4). The gene discussed is AGT; the disease is endothelial dysfunction.